SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $668,050,000 | -32.2% | 15,500 | -50.8% | 0.14% | -28.2% |
| Q1 2017 | $985,950,000 | +13.2% | 31,500 | -8.7% | 0.19% | +11.9% |
| Q4 2016 | $871,125,000 | -0.8% | 34,500 | -2.8% | 0.17% | +9.8% |
| Q3 2016 | $877,915,000 | +807.3% | 35,500 | +647.4% | 0.15% | +800.0% |
| Q2 2016 | $96,758,000 | +33.6% | 4,750 | 0.0% | 0.02% | +30.8% |
| Q1 2016 | $72,438,000 | -61.6% | 4,750 | -66.2% | 0.01% | -59.4% |
| Q4 2015 | $188,832,000 | -20.1% | 14,050 | -16.6% | 0.03% | +3.2% |
| Q3 2015 | $236,406,000 | – | 16,850 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |